Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair.
Ballout F, Lu H, Bhat N, Chen L, Peng D, Chen Z, Chen S, Sun X, Giordano S, Corso S, Zaika A, McDonald O, Livingstone AS, El-Rifai W.
Ballout F, et al. Among authors: bhat n.
Clin Cancer Res. 2024 Apr 9:OF1-OF13. doi: 10.1158/1078-0432.CCR-24-0027. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38592373